Steven J. Hattamer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Anesthesia Department, Nashua, NH 03060 Phone: 603-889-2624 |
Dr. Kate Riddell, MD Anesthesiology - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St Dept Of, Nashua, NH 03060 Phone: 603-577-2000 |
Jose Alejandro Ossa Concha, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2000 |
Kenkere G Sudhir, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 168 Kinsley St, Suite 4, Nashua, NH 03060 Phone: 603-882-1501 Fax: 603-882-9747 |
Dr. Steven E Tourangeau, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4 Stark St, Nashua, NH 03064 Phone: 603-689-8344 |
Dr. Scott W Lauer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2000 |
News Archive
What truly inspires individuals to perform at their very best? When it comes to motivating others and ourselves, it turns out offering rewards in defined categories, even when they are largely meaningless, can heighten motivation.
A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute will report today at the annual meeting of the American Association for Cancer Research.
Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering a series of weekly research-based tip sheets regarding a variety of topics related to breast cancer, including breast cancer prevention, screening and early detection, treatment, and survivorship.
Multi-tasking affects the brain's learning systems, and as a result, we do not learn as well when we are distracted, UCLA psychologists report this week in the online edition of Proceedings of the National Academy of Sciences.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the Company has received approval for its request filed with the U.S. Food and Drug Administration for Humanitarian Use Device designation for its biopolymer scaffolding product.
› Verified 1 days ago